Publications by authors named "Maarten L Simoons"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

24

Total Likes

42

Extended Reach

85,875

Social Features

14
H
High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome.
Rohit M Oemrawsingh, K Martijn Akkerhuis, Maarten de Mulder, Victor A Umans, Bas Kietselaer, Maarten L Simoons

Circulation· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ESC Publications Ethics Committee: Report from the first 5 years' experience of the European Society of Cardiology (ESC) journals family ethics committee.

Eur Heart J· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the Netherlands.
Rohit M Oemrawsingh, K Martijn Akkerhuis, Victor A Umans, Bas Kietselaer, Carl Schotborgh, Maarten L Simoons

BMJ Open· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How can the European Society of Cardiology ensure compliance with ethical standards?
Maarten L Simoons, Jean-Pierre Bassand, Jeroen Bax, Michel Bertrand, Günter Breithardt

Eur Heart J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model.
Rohit M Oemrawsingh, K Martijn Akkerhuis, Laura C Van Vark, W Ken Redekop, Goran Rudez, Maarten L Simoons

J Am Heart Assoc· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive LDL lowering therapy for prevention of recurrent cardiovascular events: a word of caution.
Maarten L Simoons, Jaap W Deckers

Eur Heart J· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis.
Michel E Bertrand, Roberto Ferrari, Willem J Remme, Maarten L Simoons, Kim M Fox

Am Heart J· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional hemodynamic resuscitation may fail to optimize tissue perfusion: an observational study on the effects of dobutamine, enoximone, and norepinephrine in patients with acute myocardial infarction complicated by cardiogenic shock.
Corstiaan A den Uil, Wim K Lagrand, Martin van der Ent, Koen Nieman, Ard Struijs, Maarten L Simoons

PLoS One· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[LDL cholesterol lowering therapy: no target value but personalised treatment].
Maarten L Simoons, Jaap W Deckers

Ned Tijdschr Geneeskd· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach.
Jorie Versmissen, Daniëlla M Oosterveer, Mojgan Yazdanpanah, Abbas Dehghan, Hilma Hólm, Maarten L Simoons

Eur J Hum Genet· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPA.
Joep van der Leeuw, Rohit M Oemrawsingh, Yolanda van der Graaf, Jasper J Brugts, Jaap W Deckers, Maarten L Simoons

Int J Cardiol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Abandon LDL cholesterol target levels].
Jaap W Deckers, Maarten L Simoons

Ned Tijdschr Geneeskd· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The grey zone of truth.
Maarten L Simoons

Eur Heart J· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk stratification for sudden cardiac death: current status and challenges for the future.
Hein J J Wellens, Peter J Schwartz, Fred W Lindemans, Alfred E Buxton, Jeffrey J Goldberger, Maarten L Simoons

Eur Heart J· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease.
Haiyan Wu, Anton J M Roks, Frank P J Leijten, Ingrid M Garrelds, Usha M Musterd-Bhaggoe, Maarten L Simoons

Clin Sci (Lond)· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
Kai M Eggers, Paul W Armstrong, Robert M Califf, Nina Johnston, Maarten L Simoons

Clin Biochem· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

Eur Heart J· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease.
Linda Battes, Rogier Barendse, Ewout W Steyerberg, Maarten L Simoons, Jaap W Deckers

Am J Cardiol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European heart journal launches ethics review board.
Thomas F Luscher, Maarten L Simoons

Eur Heart J· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy.
Freek W A Verheugt, Peter Clemmensen, Roxana Mehran, Stefan Agewall, Stuart J Pocock, Maarten L Simoons

Eur Heart J· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third universal definition of myocardial infarction.
Kristian Thygesen, Joseph S Alpert, Allan S Jaffe, Maarten L Simoons, Bernard R Chaitman

Glob Heart· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third universal definition of myocardial infarction.
Kristian Thygesen, Joseph S Alpert, Allan S Jaffe, Maarten L Simoons, Bernard R Chaitman, Maarten L Simoons

J Am Coll Cardiol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UPDATE programmes of the European Society of Cardiology.
Maarten L Simoons, Felix Zijlstra

Eur Heart J· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic influences of angiotensin-converting enzyme inhibitor response: an opportunity for personalizing therapy?
Jasper J Brugts, Maarten L Simoons

Expert Rev Cardiovasc Ther· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis